Literature DB >> 18308144

Pathologic aspects of inflammatory breast cancer: part 2. Biologic insights into its aggressive phenotype.

Yun Gong1.   

Abstract

Inflammatory breast cancer (IBC) is the most aggressive and distinct form of primary breast cancer with a peculiar clinical presentation and dismal clinical outcome. This review addresses the pathologic aspects of this entity and discusses the molecular alterations involved in the highly malignant phenotype of IBC.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18308144     DOI： 10.1053/j.seminoncol.2007.11.014

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


  14 in total

1.  GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer.

Authors:  Hugo Arias-Pulido; Melanie Royce; Yun Gong; Nancy Joste; Lesley Lomo; Sang-Joon Lee; Nabila Chaher; Claire Verschraegen; Juanita Lara; Eric R Prossnitz; Massimo Cristofanilli
Journal:  Breast Cancer Res Treat       Date:  2009-11-10       Impact factor: 4.872

2.  Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties.

Authors:  Mona M Mohamed; Eslam A El-Ghonaimy; Mohamed A Nouh; Robert J Schneider; Bonnie F Sloane; Mohamed El-Shinawi
Journal:  Int J Biochem Cell Biol       Date:  2013-11-26       Impact factor: 5.085

3.  TREATMENT OF BREAST CANCER: IMO STATE NIGERIA VERSUS INDIANA, USA WOMEN - COMPARATIVE ANALYTIC STUDY.

Authors:  A A Anele; M Bowling; G J Eckert; Elf Gonzalez; H Kipfer; C Sauder
Journal:  J West Afr Coll Surg       Date:  2014 Oct-Dec

Review 4.  EMT, MET, Plasticity, and Tumor Metastasis.

Authors:  Basil Bakir; Anna M Chiarella; Jason R Pitarresi; Anil K Rustgi
Journal:  Trends Cell Biol       Date:  2020-08-13       Impact factor: 20.808

5.  Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer.

Authors:  Deborah Silvera; Rezina Arju; Farbod Darvishian; Paul H Levine; Ladan Zolfaghari; Judith Goldberg; Tsivia Hochman; Silvia C Formenti; Robert J Schneider
Journal:  Nat Cell Biol       Date:  2009-06-14       Impact factor: 28.824

6.  Human cytomegalovirus infection enhances NF-κB/p65 signaling in inflammatory breast cancer patients.

Authors:  Mohamed El-Shinawi; Hossam Taha Mohamed; Eslam A El-Ghonaimy; Marwa Tantawy; Amal Younis; Robert J Schneider; Mona Mostafa Mohamed
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

7.  Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer.

Authors:  Hugo Arias-Pulido; Nabila Chaher; Yun Gong; Clifford Qualls; Jake Vargas; Melanie Royce
Journal:  BMC Cancer       Date:  2012-07-19       Impact factor: 4.430

8.  Cathepsin B: a potential prognostic marker for inflammatory breast cancer.

Authors:  Mohamed A Nouh; Mona M Mohamed; Mohamed El-Shinawi; Mohamed A Shaalan; Dora Cavallo-Medved; Hussein M Khaled; Bonnie F Sloane
Journal:  J Transl Med       Date:  2011-01-03       Impact factor: 5.531

9.  Monocytes conditioned media stimulate fibronectin expression and spreading of inflammatory breast cancer cells in three-dimensional culture: A mechanism mediated by IL-8 signaling pathway.

Authors:  Mona M Mohamed
Journal:  Cell Commun Signal       Date:  2012-02-10       Impact factor: 5.712

10.  Promoter hypermethylation and suppression of glutathione peroxidase 3 are associated with inflammatory breast carcinogenesis.

Authors:  Mona M Mohamed; Salwa Sabet; Dun-Fa Peng; M Akram Nouh; Mohamed El-Shinawi; Wael El-Rifai
Journal:  Oxid Med Cell Longev       Date:  2014-03-20       Impact factor: 6.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.